Cognitive behavior therapy for schizophrenia

The American Journal of Psychiatry
Douglas TurkingtonPeter J Weiden

Abstract

A growing body of evidence supports the use of cognitive behavior therapy for the treatment of schizophrenia. A course of cognitive behavior therapy, added to the antipsychotic regimen, is now considered to be an appropriate standard of care in the United Kingdom. The objective of this article is to offer a broad perspective on the subject of cognitive behavior therapy for schizophrenia for the American reader. The authors summarize current practice and data supporting the use of cognitive behavior therapy for schizophrenia. Five aspects of cognitive behavior therapy for schizophrenia are addressed: 1) evidence from randomized clinical trials, 2) currently accepted core techniques, 3) similarities to and differences from other psychosocial interventions for schizophrenia, 4) differences between the United States and United Kingdom in implementation, and 5) current directions of research. The strength of the evidence supporting cognitive behavior therapy for schizophrenia suggests that this technique should have more attention and support in the United States.

Citations

Jun 8, 2010·Current Psychiatry Reports·Marjorie Baier
Jun 2, 2010·American Journal of Psychiatric Rehabilitation·Marcela Horvitz-LennonThomas F Witheridge
Aug 22, 2006·Schizophrenia Bulletin·Josef BäumlGabriele Pitschel-Walz
Jul 3, 2009·Schizophrenia Bulletin·Alison BrabbanDouglas Turkington
Nov 24, 2006·Journal of Psychiatric Practice·Rajiv TandonUNKNOWN Treatment Effectiveness in Schizophrenia Consortium
Jan 24, 2008·Journal of Psychiatric Practice·Shanaya RathodDouglas Turkington
Mar 25, 2008·Journal of Psychiatric Practice·Heather ShibleyDavid A Kahn
Oct 4, 2008·Journal of Psychiatric Practice·Franco VeltroPierluigi Morosini
Oct 4, 2008·Journal of Psychiatric Practice·Brian J Miller
Dec 17, 2008·The Journal of Nervous and Mental Disease·David RoePaul H Lysaker
Dec 10, 2009·The Journal of Nervous and Mental Disease·Eliza Martha de Paiva BarrettoHelio Elkis
Oct 16, 2010·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Katherine E WatkinsHarold Alan Pincus
Jul 29, 2006·BMJ : British Medical Journal·David Kingdon
Nov 1, 2006·BMC Psychiatry·Yasser KhazaalValentino Pomini
Mar 14, 2012·Bulletin of the Menninger Clinic·B Christopher FruehRichard C Lindrooth
Sep 21, 2010·The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry·Ronald Abramson
Feb 8, 2007·CNS Drugs·Peter F BuckleyWilliam C Wirshing
Jul 6, 2013·Community Mental Health Journal·Narsimha R PinnintiRichard P Snyder
Aug 25, 2010·Annual Review of Psychology·Max ColtheartRyan McKay
Jun 25, 2009·International Journal of Group Psychotherapy·John R SaksaScott W Woods
Apr 2, 2008·Journal of Consulting and Clinical Psychology·Kim T MueserRosemarie Wolfe
Mar 17, 2007·International Review of Psychiatry·Bent Rosenbaum, Susanne Harder
May 21, 2011·Clinical Psychology Review·Anouk L GrubaughB Christopher Frueh
Jul 27, 2010·Trends in Cognitive Sciences·David A Clark, Aaron T Beck
Jul 22, 2010·Patient Education and Counseling·Yasser KhazaalValentino Pomini
May 23, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Henrik Lublin, Jonas Eberhard
May 24, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Robin M MurrayMarta Di Forti
Jun 17, 2008·Neuroscience and Biobehavioral Reviews·Boriana AtanasovaCatherine Belzung
Aug 28, 2007·The Psychiatric Clinics of North America·Helio Elkis
Aug 28, 2007·The Psychiatric Clinics of North America·Dawn I Velligan, Jodi M Gonzalez
Mar 29, 2007·Perspectives in Psychiatric Care·Margaret England
Feb 10, 2007·Clinical Psychology : a Publication of the Division of Clinical Psychology of the American Psychological Association·David RoePaul H Lysaker

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here